Circulars »
    Revamping of the PTUAS sub-scheme and Notification of the modification in the guidelines by Dept of Pharmaceuticals    |    CapacityBuildingProgramon“Importance of Quality Compliance & Patient Safety– Industry Practices & RegulatoryExpectations” by Pharmexcil & FDA-Goaon 27th March2024(Wednesday) at Vivanta Goa, Panaji.    |    Proposals invited for cooperation with Medical Industry Enterprises of the Novosibirsk Region in Siberia (Russia    |    NSDC organizing Employment Fair on 11.Mar.2024 at Mumbai    |    Tender Enquiry - Sri Lanka    |    Urgent Official Tender released by the MEA, GoI: Procurement and Supply of APIs to Republic of CUBA on Cost Insurance Freight (CIF) Basis    |    Interest Equalization Scheme on Pre and Post Shipment Rupee Export Credit - Extension.    |    Notification from NAFDAC Nigeria on Quality of Active Pharmaceutical Ingredients (Apis) used in the manufacture of Finished Pharmaceutical Products (FPPS) for the Nigerian market    |    Request for suggestions/inputs on Market Access Issues in China and Hong Kong    |    India - Zambia Pharmaceutical Cooperation and Regulatory Developments    |    India - Malawi Pharmaceutical Coopration and    |    DGFT's Public Notice No. 39/2023 Dt: 02 February 2024 extending the date of Track and Trace implementation up to 01.Feb.2025    |    Requirement of Vaccines by a Russian Based Company    |    Indore Capacity Building Program on “Importance of Quality Compliance & Patient Safety – Industry Practices & Regulatory Expectations” on 2nd February 2024 (Friday)    |    India Pavilion at Korea Pharm & Bio -Kintex II, Goyang, South Korea from 23-26 April 2024    |    Combat DEG Contamination: USP DEG Toolkit    |    India Pavilion at ASIA PHARMA EXPO2024, Dhaka, Bangladesh 29 Feb – 2 Mar 2024    |       |   

Forthcoming Events / News

Photo Gallery

Video Gallery